Elevated circulating CD19+CD24hiCD38hi B cells display pro-inflammatory phenotype in idiopathic membranous

Bishun Deng1, Li Deng1, Miao Liu1

  • 1Department of Laboratory Medicine, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China.

Immunology Letters
|August 8, 2023
PubMed

Insights

Regulatory B cells (CD19+CD24hiCD38hi) are increased but functionally impaired in idiopathic membranous nephropathy (IMN) patients. These cells show altered cytokine profiles, potentially contributing to IMN pathogenesis.

Area of Science:

  • Immunology
  • Nephrology
  • Cell Biology

Background:

  • Regulatory B cells, specifically CD19+CD24hiCD38hi, are known for immunosuppressive functions via IL-10 production.
  • The precise role of these regulatory B cells in idiopathic membranous nephropathy (IMN) has not been fully elucidated.

Purpose of the Study:

  • To investigate the frequency and functional characteristics of circulating CD19+CD24hiCD38hi B cells in IMN patients.
  • To assess the correlation between CD19+CD24hiCD38hi B cells and clinical parameters, as well as T helper cell subsets in IMN.
  • To evaluate changes in CD19+CD24hiCD38hi B cells following immunosuppressive treatment.

Main Methods:

  • Flow cytometry was used to determine the frequency of CD19+CD24hiCD38hi B cells.
  • Cytokine levels (IL-6, IL-10, IL-12) in B cells were analyzed.
  • T helper cell subsets (Th2, Th17) were quantified.
  • Correlations with clinical data (urinary protein, serum protein, serum albumin) were assessed.

Main Results:

  • IMN patients exhibited a higher frequency of CD19+CD24hiCD38hi B cells compared to healthy controls.
  • This frequency decreased significantly after cyclophosphamide treatment.
  • CD19+CD24hiCD38hi B cell frequency correlated positively with proteinuria and negatively with serum proteins.
  • These B cells in IMN patients showed increased IL-6 and IL-12, but decreased IL-10 production.
  • An association was found between CD19+CD24hiCD38hi B cells and Th17 cell frequency.

Conclusions:

  • CD19+CD24hiCD38hi B cells are expanded but functionally impaired in IMN patients.
  • The altered pro-inflammatory cytokine profile of these B cells may play a role in IMN pathogenesis.
  • These findings suggest a potential therapeutic target within B cell populations for IMN.